| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP0681570B1 Process for preparing quinoline amines |
| 03/14/2001 | CN1287553A Fused benzene heterocycle derivatives and utilization thereof |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity |
| 03/13/2001 | US6200976 Antithrombotic quinoxazolines |
| 03/08/2001 | WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | WO2001016107A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | WO1999039704A8 Antibacterial agents |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/08/2001 | CA2384435A1 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | CA2383307A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 03/07/2001 | EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 03/07/2001 | EP1080086A1 Dihydropyrimidines |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080074A1 New heterocyclically substituted amides, their production and their use |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP1079764A1 The treatment of sexual dysfunction in certain patient groups |
| 03/07/2001 | CN1286684A Carboxamide derivs. of pyrrolidine, piperidine and hexahydroazepine for treatment of thrombosis disorders |
| 03/06/2001 | US6197968 Storage stability; colorless after solution treatment |
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/01/2001 | WO2001014328A2 Substituted ureas as cell adhesion inhibitors |
| 03/01/2001 | DE19940394A1 New water-soluble, reactive 4,4'-cyanine dye-based fluorochromes having high quantum yield, useful as fluorescent labelling dyes for analytical use, e.g. in fluorescence immunoassays or other bioassays |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077920A1 New compounds, their preparation and use |
| 02/28/2001 | EP1077919A1 New compounds, their preparation and use |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 02/27/2001 | US6194493 4-hydroxyquinoline-3-carboxylic acid derivatives as light stabilizers |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof |
| 02/27/2001 | US6194439 Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| 02/27/2001 | US6194428 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 02/27/2001 | US6194427 Brain disorders; psychological disorders; sleep disorders; anticonvulsants |
| 02/27/2001 | CA2316662A1 Use of crf antagonists and related compositions |
| 02/22/2001 | WO2001012608A1 Quinoline compounds and process for producing the same |
| 02/22/2001 | WO2001012607A2 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 02/22/2001 | WO2001012606A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 02/22/2001 | WO2001012605A1 6,7-disubstituted-5,8-quinolinedione derivatives as an antifungal agent |
| 02/22/2001 | WO2001012600A1 INHIBITORS OF FACTOR Xa |
| 02/22/2001 | WO2001012597A2 Method for preparing quinoline-5,8-diones |
| 02/22/2001 | WO2001012591A1 Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 02/22/2001 | WO2001012187A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000071500A8 Halogen compounds |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | CA2381971A1 Amines substituted with a tetrahydroquinolinyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological acitity |
| 02/22/2001 | CA2381968A1 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 02/22/2001 | CA2380775A1 Benzoic acid derivatives and their use as ppar receptor agonists |
| 02/21/2001 | EP1076648A1 Method for the catalytic production of substituted dipyridyl derivatives |
| 02/21/2001 | EP1076557A1 Ccr-3 receptor antagonists |
| 02/21/2001 | CN1284878A Drugs augmenting NKT cells |
| 02/21/2001 | CN1062270C Amino-acid derrivatives having benzothiophene ring, prep. thereof and use as fungus-killing agent |
| 02/21/2001 | CN1062268C Alcohol to azide SN2 conversion |
| 02/21/2001 | CN1062264C Amino-acid indole or quinoline derivatives, prep. thereof and use as fungus-killing agent |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010825A1 Carbamate derivatives and agricultural/horticultural bactericides |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | DE19936472A1 Haftvermittler Adhesion promoter |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/14/2001 | EP0828714B1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
| 02/13/2001 | US6187943 Catalyzing the reaction in the presence of a metal oxide catalyst containing vanadium and/or molybdenum in a fluidized bed |
| 02/13/2001 | US6187926 Process for producing quinolone derivatives |
| 02/13/2001 | US6187786 Antitumor and anticarcinogenic agents |
| 02/13/2001 | CA2001203C Novel antimicrobial dithiocarbamoyl quinolones |
| 02/08/2001 | WO2001009099A2 Bonding agent |
| 02/08/2001 | WO2001009096A2 Potassium channel openers |
| 02/08/2001 | WO2001009095A1 Mutilin derivatives and their use as antibacterials |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/07/2001 | EP1073662A1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073631A1 New substituted amides, their production and their use |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP0533882B1 2-quinolinone derivatives, methods for preparing the same and fungicides and insecticides including them |
| 02/07/2001 | CN1283195A 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype ligands |
| 02/07/2001 | CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas |
| 02/07/2001 | CN1282737A Intermediate product used for preparing substituted quinoline-2-formamide |
| 02/07/2001 | CN1282736A Method of preparing medicinal active substance derived from quinogold |
| 02/07/2001 | CN1282735A Amphiphili 8-hydroxyquinoline complex, its preparing process and its application in electroluminescence |
| 02/06/2001 | US6184388 Antibacterial and antimicrobial, quinoline antibiotic |
| 02/06/2001 | US6184231 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/06/2001 | US6184230 Administering orally a quinolone antibiotic comprising 1-hydroxy-2-(2-trans-nonenyl)-3-methyl-4(1h)-quinolone or salt to treat gastrointestinal disorders, lymphomas, chronic heart disease |
| 02/06/2001 | CA2126118C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative |
| 02/01/2001 | WO2001007533A1 Electron-driven chirality switches |
| 02/01/2001 | WO2001007036A1 BICYCLIC ANTAGONISTS SELECTIVE FOR THE αvβ3 INTEGRIN |